Gerry Brunk is listed as a director on 8 SEC Form D filings by 2 issuers between Nov 2010 and Feb 2023: Cadence Neuroscience, Inc. (Sammamish, WA — biotechnology — 2023; $26M reported sold to 7 investors) and CARDIAC DIMENSIONS INC (Kirkland, WA — other health care — 2010–2014; $6.45M reported sold to 17 investors).
What this means 2 separate companies raised money with this person listed as director, over about 13 years. Across those companies the filings report $32.5M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 8 public filings for Gerry Brunk and found 10 differences: Gerry Brunk appears on 1 deal that stopped filing before reaching its target; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.